Global Cell and Gene Therapy Manufacturing Services Market

Global Cell and Gene Therapy Manufacturing Services Market Overview

• The Global Cell and Gene Therapy Manufacturing Services Market Size was worth around USD 4.34 Billion?in 2023 and is Predicted to Grow to around USD 21.70 Billion by 2033 with a compound annual growth rate (CAGR) Of 17.46% Between 2023 and 2033.
• The market growth is rising due to driven by Increased incidence of cancer and other other diseases, the increase in pharmaceutical R&D expenditure and collaborations and alliances between pharma firms and CDMOs are some of the drivers of the market growth.
• The cell and gene therapy manufacturing services market refers are customized contract services offered by firms to create, manufacture, and upscale cell- and gene-based treatments for clinical use and commercial applications.

Major vendors in the Global Cell and Gene Therapy Manufacturing Services Market industry

Lonza (Switzerland), Catalent, Inc. (US), Thermo Fisher Scientific, Inc. (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK), Genezen (US), FUJIFILM Holdings Corporation (Japan), Nikon Corporation (Japan), The Discovery Labs LLC (US), RoslinCT (Scotland), JRS Pharma (Germany), FinVector (Finland), ABL, Inc. (US), Resilience and others.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the cell and gene therapy manufacturing services market based on the below-mentioned segments:

Global Cell and Gene Therapy Manufacturing Services Market, By Type

• Allogeneic
• Autologous
• Viral Vector
• Non-viral vector

Global Cell and Gene Therapy Manufacturing Services Market, By Indication

• Oncology
• Orthopedic
• Ophthalmology

Global Cell and Gene Therapy Manufacturing Services Market, By Application

• Clinical
• Commercial

Global Cell and Gene Therapy Manufacturing Services Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa